m ms, narc erry avorn rcad co-director · 1:35 – 1:45 presentation: “the impact on academic...
TRANSCRIPT
![Page 1: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/1.jpg)
![Page 2: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/2.jpg)
FotodWinM
orthefirsturpartnersoimplemenevelopmen
Welookforwnsightsbyj
Michael Fis
timethisys.Wehopentyourideant,orevalua
wardtoyouoininguso
scher, MD,
year,thematheirpreseas.Whetheration,NaRC
urcontribuonsocialme
, MS, NaRC
ajorityofthentationswryouneedCADstands
utions.Aspaedia,andst
CAD Direc
heconferenwillinspireysupportonreadytow
artofourctayingconn
ctor J
WelcomeConferencthankyoupastyear,innovatioorganizatcollaboratopportunmorewidThisyear’successfuUnitedStathattheinconnectioyourownofcarean
nceagendacyoutoconnntraining,pworkwithyo
ommunity,nectedtoou
erry Avorn
tothe4thInceonAcadeuforbeingh,we’veseennsfromouions,formetions,andiitiesforADely.
’sconferenlADprograatesandthnspirationyonsyoumakworkonimndpatiento
consistsofnectwithNprogramplaou.
,wehopeyurnetwork.
n, MD, Na
nternationaemicDetailhere!DurinnamazingrpartneredexcitingdentifiedDtobeadop
cewillhighamsfromaeworld.Wyoureceivekeherewilmprovingthoutcomes.
submissionaRCADtolanning,mat
you’llshare.
aRCAD Co
alling—wengthe
new
ptedeven
hlightroundtheehopeeandlmotivatehequality
nsfromearnhowterials
your
o-Director
![Page 3: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/3.jpg)
![Page 4: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/4.jpg)
DAY 1: MONDAY, NOVEMBER 14TH, 2016 DetailedAgenda&SessionDescriptions
AllmainsessionswillbeheldintheRotundawiththeexceptionofafternoonbreakoutsasnotedPresentationslideswillbeavailableatonourConferenceHubpageatnarcad.orgaftertheconference
8:30AM Breakfast&Networking
9:00AM OPENINGREMARKS:WelcometoNaRCAD2016MichaelFischer,MD,MS,NaRCADDirector
9:30AM KEYNOTETALK:“TheUSPreventiveServicesTaskForce&ImprovingPreventioninPrimaryCare”AnnKurth,PhD,CNM,MPH,FAANDeanandLindaKochLorimerProfessor,YaleUniversitySchoolofNursing
10:15AM MorningBreak
10:30AM EXPERTPANEL:“EngagingMedicalSpecialistsinAD:FromTopicDevelopmenttoDelivery”Moderator:AmandaKennedy,PharmD,BCPSPanelists:LynetteKosar,BSP,MSc,CaitO’Sullivan,BA,BScPh,PharmD,&SarahBall,PharmDThispanelexploresADexperts’professionalexperienceincollaboratingwithmedicalspecialistswhentakingaclinicaltopicfromevidencebaseto1:1deliveryinthefield.Thesessionwillreviewtheadvantagesandchallengesofconsultingwithspecialists,suchasrecognizingthedifferenceinperspectivesbetweenspecialistandprimarycareclinicians.Panelistswillsharestoriesofsuccess,balancingthatwithstrategiestoaddressbarriers,includingrespondingtospecialists’disagreementswithmessagingandmaterials.Opportunitiesforparticipantstoshareexperienceswillbewoventhroughout,withafinalaudienceQ+Aattheendofthepanel.
12:00PM
Lunch
1:00PM
BREAKOUTSESSIONS:“ADinAction”Choosefrom3TrackSelections:
Breakout1:DeconstructingtheADVisitAmandaKennedy,PharmD,BCPS,&BevinK.ShagouryWhatreallyhappensduringa1:1visitwithaclinician?Howdoacademicdetailerspreparetomakeeveryvisitcount?JointhishighlyinteractivesessionfacilitatedbymembersoftheNaRCAD training teamas theybreakdown thekey elements of a successful educationalvisit through small group exercises and problem‐solving. This sessionwill be especiallybeneficialforattendeespreparingtoworkasclinicaleducators,orforthoseseekingnewinsightsandskillsrefinement.Agreatintroductiontothefundamentalsofavisit,andidealforthoseplanningtocompleteafutureNaRCADADtechniquestraining.
![Page 5: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/5.jpg)
Breakout2:It’sAllintheDetailer:ATeam‐BuildingPerspectiveLorenRegier,BA,BSP,TerrynNaumann,BScPh,PharmD,&JessRogersAn effective clinical education program is only as strong as the teambehind it. Howdoexperts in the fieldstayconnectedamidst thechallengesofdiversegeographies,detailerisolation, and behavioral or clinical topic pushback from clinician audiences? Ideal forconference attendees who are initiating new programming and are interested in thecornerstonesofcreatingandgrowingasuccessfulteam.AlsoimportantforthosewhoareactivelymanagingADorrelatededucationaloutreachprogramsandareseekingstrategiestomaketheirteamsmoreeffective.Breakout3:BuildingStrategicPartnerships:IncreasingAccess&ImpactMindyCraig&MikeFischer,MD,MSADprogramsdonotworkinavacuum–successrequiresidentifyingwaysinwhichADcaninteractandbesynergisticwithotherlocalinitiatives.Makingtheseconnectionsrequirescarefullybuildingcollaborationswithlocalpartners.Thissessionwillfocusonhowtogrowacademicdetailingprogramsbybuildingstrongrelationshipswithvariouscommunitystakeholdersforsustainableimpact.
2:30PM AfternoonBreak:Coffee&NetworkingEnjoyanextendedbreak tosharewhatyou’ve learnedatyourbreakoutsession,relax,andconnectwithNaRCADstaffaboutyourprogramming.
3:00PM SPECIALPRESENTATION:“TobaccoTreatmentforPeoplewithSeriousMentalIllness:ACollaborationwithNaRCAD”MarkViron,MD,KathrynZioto,MD,GailLevine,MDMassachusettsMentalHealthCenterPeoplewithseriousmentalillness(SMI)intheUnitedStatesdie,onaverage,25yearsearlierthanthegeneralpopulation.Muchofthisexcessmortalityisdrivenbysmoking,asnearlyhalfofalldeathsinpeoplewithSMIareduetotobacco‐relatedmedicalconditions.LearnfromtheteamatMassMentalHealthCenterinBostonastheydescribetheircollaborationwithNaRCADtoincreasetobaccocessationstreatmentforpatientswithSMIthroughdirectoutreacheducationwithmentalhealthclinicians.TheMMHCteamwillsharemoreabouttheneedtoaddressthisissue,thedevelopmentoftheirintervention,andtheirmostcurrentdataandoutcomes.
3:45PM “Thebiomedicalinformationexplosion,risingcosts,&clinicianburnout:Howacademicdetailingcanhelp.”Dataontheuseofmedicationsandothermedicalproductsandservicesareaccumulatingexponentially,risingcostsareincreasingtheanxietyofpatientsandpayors,andprimarycarecliniciansareundergrowingpressureoverboth.Whilenopanacea,academicdetailingcandoagreatdealtoaddresseachoftheseevolvingissues.JerryAvorn,MD,Co‐DirectorofNaRCAD
4:30PM Day1ClosingRemarksMichaelFischer,MD,MS,DirectorofNaRCADPleasetakeamomenttofilloutourDay1Evaluationform.
5:00PM‐6:00PM
EveningNetworkingReceptionJoinusjustoutsidetheRotundaforhorsd'oeuvresanddrinks!
![Page 6: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/6.jpg)
DAY 2: TUESDAY, NOVEMBER 15TH, 2016 DetailedAgenda&SessionDescriptions
AllsessionswillbeheldintheRotundawiththeexceptionofafternoonbreakoutsasnotedPresentationslideswillbeavailableonourConferenceHubpageatnarcad.orgaftertheconference
8:30AM Breakfast&Networking
9:00AM ReflectionsonLearning:WelcometoDay2MichaelFischer,MD,MS,DirectorofNaRCAD
9:15AM KEYNOTETALK:“EngagingProfessionalSocietiesinImprovingtheQualityofCare:AViewfromtheAmericanCollegeofPhysicians”StevenWeinberger,MD,MACP,FRCPAssociateExecutiveVicePresident,ExecutiveVicePresidentChiefExecutiveOfficerEmeritusAmericanCollegeofPhysicians
10:00AM MorningBreak
10:15AM THEMEDPLENARY:“AcademicDetailing&theOpioidCrisis”Front‐linecliniciansplayanintegralroleinaddressingthecurrentopioidepidemicintheUnitedStates.Thisspecialplenarywillincludepresentationsoninnovativeinterventionscurrentlybeingimplemented,openingupdiscussiononthedifferentclinicaloutreacheducationstrategiesforimprovingthesafetyofopioiduseandtheeffectivenessofchronicpainmanagement.Moderator:KarenLasser,MD,MPHFeaturingPresentationsfrom:
JamesRick,MD&MichaelAscari,PharmD,MHALongBeach,CaliforniaVeteransHealthAdministration
RobertRhyne,MD,&DanelleCallan,MAUniversityofNewMexicoHealthSciencesCenter
MelissaChristopher,PharmD&MarkBounthavong,MPH,PhDVeteransHealthAdministration’sNationalADService
12:00PM
12:45PM
LunchFIELDPRESENTATIONS:“ImprovingOutcomesAcrossaGlobalHealthcareLandscape”Seefollowingpageformoredetailonthiscollectionofhighlightedinterventions.
![Page 7: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/7.jpg)
#NaRCAD2016 Field Presentations: “ImprovingOutcomesAcrossaGlobalHealthcareLandscape”
ArapidroundofhighlightsfromrecentfieldinterventionsDay2|12:45–2:30p.m.
12:45–12:50 FieldPresentations:TheImportanceofSharingBestPractices
MikeFischer,MD,MS12:50–1:00 Presentation:“ImplementationofanIntegratedApproachtoSafeOpioid
PrescribingandMonitoring” SameerV.Awsare,MD,FACP
ThePermanenteMedicalGroup,California
1:00–1:05 AudienceQ+A
1:05–1:15 Presentation:“Comparisonoftwomethodsofintroductiontoanacademic
detailingprogram:ADHDtreatmentamongpediatricMedicaidpatients.” JackiTravers,PharmDPharmacyManagementConsultants,OklahomaCity,Oklahoma
1:15–1:20 AudienceQ+A1:20–1:30 Presentation:“TheImpactofLiveWebinarEducationalSessionsonPharmacists’
Learning:PilotProjectinOptimizingProton‐PumpInhibitorUseinPrimaryCare.” ShirleyYeung,BSc(Pharm),ACPR,MScPublicHealth
BCProvincialAcademicDetailingService,Vancouver,BC,Canada
1:30–1:35 AudienceQ+A
1:35–1:45 Presentation:“TheImpactonAcademicDetailingofaDrugTherapyPointof
CareTool/Resource(RxFilesDrugCharts)”BrentJensen,BSPRxFilesAcademicDetailingProgram,Saskatoon,SK,Canada
1:45–1:50 AudienceQ+A
1:50–2:10 Presentation:“ADinNorway:WiserUseofNSAIDs&Antibiotics” HaraldChristianLangaas,MPharm,MPH
DepartmentforClinicalPharmacologyandtheRegionalMedicinesInformationandPharmacovigilanceCenter(RELIS),St.Olav’sHospital,Trondheim,Norway
2:10–2:15 AudienceQ+A
2:15–2:25 ContinuedDialogue:AudienceQ+Aforallpresenters2:25–2:30 FieldPresentationOpportunitiesfor2017
Briefreviewoftheprocessforsubmittingpresentationproposals,withalookaheadto2017.NaRCADencouragesyoutomeet&chatwiththe2016FieldPresentersduringtheupcomingafternooncoffeebreak!
![Page 8: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/8.jpg)
DAY 2: TUESDAY, NOVEMBER 15TH, 2016 DetailedAgenda&SessionDescriptions,Continued
2:30PM AfternoonBreak:Coffee&NetworkingEnjoyanextendedcoffeebreaktoconnectwithspeakersfromtheFieldPresentationsession,prepare foryourafternoonbreakout session, relax,and connectwithNaRCAD staffaboutyourprogramming.
3:00PM
4:30PM
BREAKOUTSESSIONS:“AdvancedLessonsinAD”Choosefrom3TrackSelections:
Breakout1:CreatingClearMessagingfromComplexClinicalTopicsLynetteKosar,BSP,MSc,BrendaSchuster,BSP,ACPR,PharmD,FCSHPAnacademicdetailingtopiccanbecomplexforavarietyofreasons,includingthequantityandqualityoftheevidence,thenumberoftreatmentchoices,orhealthcaresystemissuesthatcontributetogapsinpractice.Thissessionwillhelpparticipantstounderstandandaddressthechallengeofcreatingclear,evidence‐basedmessaging.Participantswillworkwithacomplextopic,activelystrategizingwaystotranslateclinicalinformationintodynamic,engaging,andeffectivecontent.Breakout2:TopicWorkshop:OpioidSafetyinDiverseSettingsRobertRhyne,MD,DanelleCallan,MA,AlishaHerrick,MPH,CHESJamesRick,MD,PriyankaRanderia,MHA,MPHBuildinguponthefoundationlaidbytheThemedPlenary,“AcademicDetailing&theOpioidCrisis”,thisworkshopfeaturestwoofthismorning’splenaryteamsastheyencourageattendeestoproblem‐solvestrategiestoaddresssystemicchallengestoimproveopioidsafety.Idealforattendeeslookingtoexaminewaystoaddressprogrammatic,geographic,andbehavioralchallengestosimilaropioid‐directedinterventions,andwhowanttotakeawaypracticalstrategiesthatcanbeappliedtoprogramsaddressingbehaviorchangearoundrelatedtopicsinprescribingandchronicdiseasemanagement.Breakout3:PragmaticProgramEvaluationNiteeshChoudhry,MD,PhD&MelissaChristopher,PharmDTheevidencebaseforADiswell‐established,fromJerryAvorn’soriginalrandomizedtrialsthroughrecentsystematicreviewsofthemanyfollow‐onstudies.ButforADprograms,likeotherqualityimprovementinterventions,thereisalsotheneedtoassessongoingimpactwithawell‐designedevaluationprocess.Thissessionwillprovideparticipantswithboththeprinciplesofrigorousevaluationaswellasspecific,appliedcasestudies.AhighlyrelevantsessionforADpractitionersormanagersseekingtomonitorandimprovetheirprograms;payersandpolicymakersoverseeingoutreacheducationinitiatives;andresearchersplanningstudiesofAD.ClosingRemarks,FinalAudienceQ+A,&StayingConnectedwithNaRCADTheNaRCADHomeTeam
5:00PM
TowrapupDay2,membersofNaRCAD’shometeamwillfieldquestions,sharevirtualresources,anddiscussthemomentuminthefieldasweheadinto2017.ConferenceAdjournmentPleasecompleteyourDay2Evaluations.
![Page 9: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/9.jpg)
arc
&acust
Find
AD‐re Suppohivalconfetomresour
narcwhat you
Fe Tools Webin
elatedpublortmateriaerenceserircequeryfo
cad.orgu need to
eaturins,guides,&nars&preslications&alsonavariescontentormsowe
g/learno make yo
g: tipsheetssentationsfeaturesinrietyofclint,includingcanhelpy
ning-ceour progr
nthenewsnicaltopicsgon‐demanyoufindwh
enter ram stron
ndvideohatyounee
nger.
ed.
![Page 10: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/10.jpg)
Day 1 Keynote Biography: ANN KURTH, PhD, CNM, MPH, FAAN DeanandLindaKochLorimerProfessor
YaleUniversitySchoolofNursing
Ann E. Kurth, PhD, CNM, MPH, FAAN is Dean, and Linda KochLorimerProfessor(inauguralchair)of theYaleUniversitySchoolof Nursing. She previously held the inaugural Paulette GoddardChair in Global Health Nursing at New York University (NYU)College of Nursing and was Associate Dean for Research at theNYUCollegeofGlobalPublicHealth.Sheisamemberofthe2014‐2018USPreventiveServicesTaskForce,whichsetsscreeningandprimarycarepreventionguidelinesfortheU.S.
As an epidemiologist and clinically‐trained nurse‐midwife Dr.KurthfocusesonHIV/sexualandreproductivehealthprevention,screening and care, as well as on global health systemstrengthening,usinginformationandcommunicationtechnologiesamong other approaches for health intervention and workforceeducation implementation. Her work has been funded by theNationalInstitutesofHealth(NIAID,NIDA,NIMH,NICHD),theBill
&MelindaGatesFoundation,UNAIDS,CDC,HRSA,andothers,forstudiesconductedintheUnitedStatesandinternationally.Dr.KurthhasconsultedfortheNIH,GatesFoundation,WHO,USAIDandCDC,amongothers.Dr.Kurthhaspublishedover170peer‐reviewedarticles,bookchapters,andscholarlymonographs,including editing one of the first books published on women and HIV (Until the Cure, YaleUniversityPress1993).Dr.Kurthhas receivedawards forher scienceand leadership includingtheFriendsoftheNationalInstituteofNursingResearchAdaSueHinshawResearchAwardandtheInternationalNurseResearcherHallofFameawardfromSigmaThetaTauInternational.Dr.KurthisvicechairoftheConsortiumofUniversitiesforGlobalHealth(thefirstnon‐physicianinthisrole),andaFellowof theAmericanAcademyofNursingandof theNewYorkAcademyofMedicine.Dr. Kurthwas elected as a Fellow to the Institute ofMedicine/National Academy ofMedicinein2013.Dr. Kurth received her A.B. in development studies and African studies from PrincetonUniversity. She earned anM.P.H. from the Columbia University School of Public Health in theDivisionofPopulationandFamilyHealth,witha focusonmaternalandchildhealth.Dr.KurthcompletedherM.S.N.attheYaleUniversitySchoolofNursing,Maternal‐NewbornDivisionandisacertifiednursemidwife (C.N.M.)andregisterednurse (R.N.).ShewasaNational InstitutesofHealth predoctoral fellow in sexually transmitted diseases and U.S. Public Health Servicematernal and childhealth economic fellowat theUniversityofWashington,where she earnedherPh.D.inepidemiology,withaminorinhealthservices.
![Page 11: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/11.jpg)
Day 2 Keynote Biography: STEVEN E. WEINBERGER, MD, MACP, FRCP
AssociateExecutiveVicePresident,ExecutiveVicePresident,ChiefExecutiveOfficerEmeritus,AmericanCollegeofPhysicians
Steven Weinberger, MD, MACP, FRCP, recently retired from hisposition as Executive Vice President and Chief Executive Officer(EVP/CEO) of the American College of Physicians (ACP) and iscurrently serving for one year as Associate Executive VicePresident to help with the transition to a new EVP/CEO. HeassumedthepositionofEVP/CEOin2010,afterhavingservedfor6yearsasACP’sSeniorVicePresident forMedicalEducationandPublishing.Aninternistandpulmonologist,Dr.WeinbergerisalsoAdjunct Professor of Medicine at the University of PennsylvaniaandSeniorLectureronMedicineatHarvardMedicalSchool.DuringhistenureatACP,Dr.WeinbergerinitiatedanddevelopedACP’sHighValueCareInitiative,focusedonreducingoveruseandmisuse of care that adds to healthcare costs without benefiting
patients. He also created ACP’s Center for Patient Partnership in Healthcare (CPPH), whichpromoteshealthcare asapartnershipbetweenpatientsandclinicians. TheCPPHcollaborateswithpatientandfamilyorganizationstofurtheracultureinwhichpatientsnotonlyarepartnersintheirowncare,buttheyalsopartnerwithcliniciansandhealthcarepracticesandsystemstoimprovethewaythatcareisdelivered.PriortojoiningACP,Dr.Weinbergerservedonthefull‐timefacultyatHarvardformorethan25years. He was Executive Vice Chair of the Department of Medicine at Beth Israel DeaconessMedical Center, ExecutiveDirector of the Carl J. Shapiro Institute for Education andResearch,and Professor ofMedicine and Faculty Associate Dean forMedical Education at Harvard. Dr.Weinberger has authored over 140 articles and book chapters aswell as a popular textbook,PrinciplesofPulmonaryMedicine,nowinitssixtheditionandtranslatedintomultiplelanguages.He has served on the Editorial Board of The New England Journal ofMedicine and was theFoundingEditor‐in‐ChiefofthePulmonaryandCriticalCareMedicinecomponentofUpToDate.Dr.WeinbergerreceivedhisM.D.fromHarvardandresidencytrainingininternalmedicineattheUniversityofCalifornia‐SanFrancisco,followedbyfellowshiptraininginpulmonarymedicineatthe National Heart, Lung and Blood Institute. He is the recipient of numerous national andHarvard Medical School teaching awards. Dr. Weinberger has been named a Master of theAmerican College of Physicians and a Fellow of the Royal College of Physicians (London). Inappreciationofhisleadership,ACP’sBoardofRegentsrecentlyestablishedanewannualaward,theStevenE.WeinbergerAwardforPhysicianExecutives/Leaders.
![Page 12: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/12.jpg)
N
NaRCAAD Sta JeDr.DivgerdetoptincthepatandtraSchHoPhStaautoutme
MiDr.resactextmegaireiFisSciHeBricomand
NiDr.PhythetheandconchrinitrescosandsysDeme
ff erryAvorn. Avorn is Pvision of Phriatrician, atailinganditimal medicclude:thesceidentificatitients;progrd pharmaceaining at Colhool in 197ospital in Boarmacoepidandardsforthor of ovetcomes, andedicineandt
ichaelFis.Fischerisasearcher.Hetiveprimarytensiveexpeedicationuseinsfromimpmbursemenscherearnediencedegreealth.Hecomigham&Womponentsofdteachesco
iteeshCho.ChoudhryiysicianintheHospitalistedevelopmedreducespensequencesroniccondittiationandlsearchprogrst‐effectivendcollaboratstems.HeisliveryScienedicineatBr
n,MD|CoProfessor ofharmacoepidanddrug episrecognizecation use, pcientific,poliionandprevramstoimpeutical cost‐lumbiaUniv74, and comoston. He hdemiologyanDevelopingr 500 paped isoneof tthesocialsc
scher,MDageneralinteisanAssocycarephysicerienceindeeandhaspuprovedprescntpolicy,eledhismedicaeinhealthpmpletedresidomen’sHospftheinternaoursesonres
oudhry,MisaProfessohe Division otProgramatentandevaluending.Heisofusingevidtionsandindlong‐termmramfundednessofmedicteswithawialsothefouces. Dr.ChorighamandW
o‐Directorf Medicinedemiology apidemiologisdinternatioparticularlyicy,andsociventionofaprovetheapeffectivenesversity in 19mpleted a rehas served andisamemTrustworthers in the mthemosthigiences.
D,MS|Direternist,phariateProfesscianandeduesigningandublishednumcribing.Hisectronicpresaldegreefromolicyandmadencytrainipital.Heteacalmedicinersearchmeth
MD,PhD|orofMedicinof PharmacotBrighamanuationofnosparticularldence‐baseddesigningstmedicationadbyCVSCarecaltechnoloiderangeofundingExecuudhrypractWomen’sHo
at Harvardand Pharmast, he piononallyasaley in the eldeialfactorsthdversedrugpropriateness analysis.969, receiveesidency inas presidentberoftheInyClinicalPrmedical literghly‐cited re
ectormacoepidemorofMediciucatoratBridevaluatingmerousstudresearchintscribing,andmtheYaleSanagementfnginprimachesinbothresidencyprhodologyatH
ProgramFneatHarvaroepidemiologndWomen’svelstrategielyinteresteddtherapiesftrategiestoodherence.Hemarktostuogiesandcominsurers,emutiveDirectoticesinpatienospital.
Medical Sccoeconomicneered theeadingexpeerly. His mahatshapephgeffects;meessofprescrDr. Avorn ded hisM.D.internal mt of the IntnstituteofMracticeGuidrature on mesearchersw
miologist,anineatHarvagham&WominterventiondiesdemonstterestsincludmedicationSchoolofMefromtheHarycareintertheoutpatierogramatBrHarvardSch
FacultyrdMedicalScgy and PharmsHospital.HestoimprovdintheclinicforthemanaovercomebaeleadsamuudymedicatimparativeefmployersandoroftheCenntgeneralin
chool and Ccs. A generaconcept ofrtonthistoajor areas ohysicians’dredicationadhribingandddid his undfromHarvaedicine at Bternational SMedicineComelines.Dr.Amedication uworking in t
ndhealthserrdandaclinmen’sHospinstoimprovtratingthepudeprescriptnadherenceedicineandarvardSchoornalmedicinentandinparigham&WhoolofPubli
choolandanmacoeconomisresearchfvehealthcarcalandeconagementofcarrierstotreultidisciplinaionadherenffectivenessdhealthdelnterforHealnternal/hosp
hief of theal internist,f academicopicandonof researchugchoices;herencebydrugtaking;ergraduateardMedicalBeth IsraelSociety formmitteeonAvornistheuse and itstheareaof
rvicesnicallyital.Hehasvepotentialtiondrug.Dr.aMasterofolofPublicneatatientomen’scHealth.
nAssociatemicsandfocusesonrequalitynomiccommoneatmentaryce,theresearchiverylthcarepital
![Page 13: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/13.jpg)
BeBevmadevclaDEpraexptoicuredu
ArAriTecaloMafrocooheathacom
JuJulAcaBaAssparoutinn
evinKathvinmanageanagement,velopedcomassrooms,anETAILS blogactices andperience inintegratedrricula,Beviucation,focu
rielleMatiellemanagechniques seongwith facaster’s Degrom Tufts Unordinating Balthyagingwatenhancetmmunities.
lieBarbeie assists NademicDetachelor of Ssistant inthrticipates intcomes ofnovationinto
leenShages NaRCAD’sgrant wr
mmunicationndhealthcarg, e‐newsletmagnify th
n buildinglearning pin graduateusingonser
ther,MPHesallofNaReries and thcilitating theee in Publicniversity ScBoston‐baseworkshops,thequalityo
erio|EventNaRCAD eveailing and thScience degheDivisionon the implemedicationsopracticeas
goury|Cos external coriting, andns and educre‐basednontter, and phe impact ostrategic
platforms, ad fromEmervingmargin
H|EducatioRCAD’sevenhe annual Ine developmec Healthwithool of Meed elder serandispassioflifeandim
tsAssistantents, includheAcademiree from BofPharmacoementations. She putssapartofth
ommunicatiommunicatid marketincational resn‐profits,Beartner netwof clinical epartnershiand develoerson Collenalizedyouth
on&Trainints,includingnternationaent of clinicth a concendicine. Shervice prograionateaboutmprovethe
ting the annicDetailingBrandeis Unoepidemioloof researchs her passiheNaRCADt
ions&Educions, bringinng skills tsourcesin cvinmanagework, workeducation pips,improvinoping educge with ah.
ingManagegtheAcadel Academiccalmaterialntration in Hhas severa
ams and teatconnectinghealthstatu
nual InternaTraining Seniversity inogyandPhastudies relions of leateam.
cationDireng non‐profto NaRCADlinical settistheNaRCAking to highprograms. Wngcommunicational anddegree in
ermicDetailinDetailing Cs. Arielle reHealth Commal years ofaching evidegotherswithusoftheirfa
ational Conferies. She re2016.As a
armacoeconolated to therning and
ectorfit programD. Havingngs, urbanADwebsite,hlight bestWithcareerity accessd trainingexpressive
ngTrainingConference,eceived hermunicationexperienceence‐basedhresourcesamiliesand
ference oneceived hera Researchomics, Juliee uses andhealthcare
![Page 14: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/14.jpg)
2016
MiChDr.ofcomMetheVAcurchaincand
SaAssSamgra25AssPhOutheMeDiralsBo
SaResGeSarChmea jDecoleduAcajoinsigph
6 Conf
ichaelAsciefofPharm.MichaelAsPharmacy ampletedhisedical CenteePacificandA Long Beacrrently purampioned nclude systemdoutcomes
ameerV.AsociateExecmeer V. Awaduatedfromyears. Dr.sociate Exearmacy, AduutsideMediceHospitalEedical Grouprectors sinceoservedasardfrom20
arahBall,searchAssiriatricsMedrah Ball recarleston, Soedicalhomeoint appoinpartmentofllaborate wucational ouademic Detning the Degnificantexparmacyacad
ference
cari,Pharmacyatthescarireceiveand his MHpostgradur.Dr.Ascardservesonh Healthcarrsuing hisnumerous pems redesignresearch.
Awsare,McutiveDirecwsare, MD, pmUniversityAwsare joincutive Direult and FamcalServices.thicsCommp’s Campbee1997 to2Chairofthe006to2014.
PharmDistantProfedicalUniverently joinedouth Carolitransformantment as CfClinicalPhwith the Coutreach forailing Serviepartment operiencewithdemicdetail
e Spea
rmD,MHAVALongBeedhisPharmHA from theateresidencri holds an anumeroushre SystemPBlackbelt cerformance, continuou
MD,FACPctor,ThePepractices IntyofCalifornned the Perctor for ThmilyMedicinHeisalsoin
mittee,andsell facility. 2014, andseeBoard’sGo
essor,DivisiorsityofSoutd the Medicina, with cationandprClinical Assiarmacyandollege of Ppractice bece at the Sof Medicinehtheeducatlersandevid
aker Bio
AeachHealthmDfromthee CaliforniacyinClinicaacademic aphospitalcomPharmacy ancertificationimprovemes quality im
ermanenteMternal Medicnia,Irvineinrmanente Mhe Permanene, Risk AdjnvolvedinrervedasChHe has beeervedas itsvernanceCo
onofGenerthCarolinacal Universiurrent conescriptiondstant ProfesdOutcomeSPharmacy inhavior chanouth Carolie. As foundtion,trainindence‐based
ograph
careSystemUniversityoState UnivealPharmacyppointmentmmitteesincnd Therapeuin LEAN
ent projectsmprovement
MedicalGrocine in Cam1989andh
Medical Grouente Medicausted CodinresidentteaciefofMedicen a membsecretary frommitteean
ralInternal(MUSC)ity of Southcentrationsdrugoverdosssor in theciences,atMn projectsnge. Dr. Ballna Collegeing directorgandfieldmdcontentdev
hies
mofRhodeIslersity, LongyattheLongwith theUncludingCo‐Cutics Commiand has s. His areast, pharmaco
oup(TPMG)mpbell, CA. Dhasbeeninpup in 1993,al Group inng, Revenueching,wastcineatthePer of TPMGrom2000 tondtheViceC
Medicinean
h Carolinaon patientsepreventioCollege of
MUSCandcoinvolvingl directed thof Pharmacr of SCORxmanagemenvelopment.
landSchoolBeach. HegBeachVAniversity ofChairoftheittee. He isuccessfullyof interesteconomics,
Dr. Awsarepracticefor, and is ancharge of
e Cycle andtheChairofPermanenteG Board ofo2006.HeChairofthe
nd
(MUSC) int centeredon.ShehasPharmacy,ontinuestoinnovativehe SCORxEcy prior toE, she hastofclinical
![Page 15: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/15.jpg)
MaProDr.HeVetOuSciaswodirPutheWaMaDaProDeDacerskiforcartobac20volwoaddadm
MeNaOffDr.oveVetPhPhForconchrtheimSchdismatowe
arkBounogramMan.Bounthavoalth Sciencterans Affautcomes Resiences.Hesta pharmac
orked on irectedthePGblicHealthfe Pharmaceuashington.Hanagersinth
anelleCalojectManaepartmentonelleC.Callrtificationinills inpractirthepastfourdiovasculardisseminatechelor'sdeg05andrecelunteer fororth sharingdition, she iministration
elissaChrationalDirecffice,Pharm._Christopheerseeingtheteran Integarmacy fromarmacyPracrmulary Manductedreseronicdiseasemissiontoprovementhizophrenia,sorders. Moaterials,outctrendpractiellasfullyim
nthavong,nager,Acadonggraduatees. He comirs Loma Lsearch andtartedhiscaoeconomicsdentifyingGY‐1ManagfromEmoryutical OutcoHerecentlyaheAcademic
llan,MAager,UniverofFamilyaanhasbeennacademicdice facilitatiouryears.Herdisease(ABe best practgreeinanthrivedhermaTEDxABQ ag. She has vois one of thnresourcefo
ristopherctorAcademacyBenefitser is the Ne implementgrated Servim DuquesnecticeResideanagementearchinheasemanagemoexpandeffof eviden
, and Posttrost of her pcomemoniticepatternsmplemented
MPH,PhDdemicDetailedfromthempleted a PLinda HealtPharmacoe
areerattheVs clinical spcost‐effectivgedCarePhayUniversity.omes ReseaacceptedapcDetailingSe
rsityofNewndCommunanemployedetailingfromonandacaderprojectexBC’s)andwotices and evropologyandaster’sdegreas the speaolunteerede PCORI amorherdepar
r,PharmDmicDetailinsManagemNational Dirtationeffortice Networke UniversityncyandPosat VA Sanalthoutcomementareas.Inforts foredunce basedraumatic Strprogram efors,provideswithimpleADprogram
DlingServiceCollegeofPPGY‐1 Pharthcare Systeeconomics aVeteransAfpecialist. Duve strategiearmacyResi.Markleftthrch and Polpositionattervice.
wMexico'sHnityMedicieeofUNMfmNaRCADidemicdetailxpertiseisonorkingwithvidence‐basdeconomicseeinHealthker liaisonas a grant rmbassadorsrtmentongr
Dng,U.S.Deptment(PBM)Arector of Vts foracademks since 20y, PittsburghstGraduateYn Diego Heesandpharmnrecentyeaucationaloucare in
ress Disordefforts focuserspecificelementationems.
e,VeteransPharmacyatmacy Practem followedat WesternffairsSanDieuring his tenes and foridency;andheVAinordlicy ProgramtheVAason
HealthScieineforover10yin2013andlingonmultnchronicnoruralprovided informatswhichsheEconomicsencouraginreviewer foratUNMandrantapplicat
t.ofVeteranAcademicDVA Academmicdetailin014. She reh PennsylvaYear2inPhalthcare Symacoeconomars,Dr.ChriutreachbyclPain Manaer aswell aon developlectronicaueffortsforth
sAffairsWesternUntice Residend by a fellUniversityegoHealthcnure at thermulary macompletedadertopursum at the UnneoftheNa
encesCente
years.Sherehasbeenaptiple researcon‐cancerpadersandclintion. She horeceivedfroin2011.Dang the sprear PCORI andd a contracttions.
nsAffairsCeDetailingSermic Detailingngexpansioneceived herania. She coharmacoeconystem.Dr. Cmicanalysisistopherhaslinicalpharmagement, Das other subpment of euditandfeedhenewlyde
niversityofncy at thelowship inof HealthareSysteme VA, Markanagement;aMasterofueaPhDinniversity oftionalData
r,
eceivedherpplyingherchprojectsain(CNCP),nicsystemsolds a duelomUNMinnellewasaad of ideasdHRSA. Int and grant
entralrviceg Services,nacrossallDoctor of
ompleted anomicsandChristopherforseveralsembracedmacists forDepression,bstance useeducationaldbacktoolsevelopedas
![Page 16: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/16.jpg)
MiDirMintheColproresphyteametoher
AlProHeAliMecomacaacWoaspromama
BrAcaBreSashechodruprehosint
AmDirAm20DeVerboameawpatStaRh
indyCraigrectorofPhndyhasbeeeclinicalsetlorado Heaogram inMsearchtoeaysicianassisam.Hermeedicalrecordfullyundersrtodelivert
ishaHerrogramSpecealthExtenssha works fexicowheremmunitypaademicdetaichronicdiseaorth,Texas.Sa Peace Cooviding theaster traineranagementp
rentJenseademicDetent currenskatchewanseeshundrosenbyfamug comparisesentingclinspital pharmterestinpsy
mandaKerector,Vermmandahasd03. Amandatailing Techrmont, Colleard‐certifiededication saward(K08),atient safety.ate of Vermeumatology
g,PA‐C,MhysicianOutenwiththeAtting. Sheeaalth Scienceay 2000. CrnherMaststantinanuedical careerdsclerktopstandtheuntechnicalass
rick,MPH,cialist,SoutsionRuralOfor the SoutsheprovidertnersandoilerforastatasebilingualShemanageorps voluntenecessary cur in Motivatiprogram.
en,BSPtailer&Drugtly worksasadetaileedsofSaska
milyphysiciason charts onicaltrialevmacist for Schiatry,geri
ennedy,PmontAcademeliveredAcaa regularlyhniques traiege of Medidpharmacisafety througagraduatec. Her primaont, and locyattheUVM
MStreach,ColoABCDteamarnedherpe Center’soncurrentlyterofSciencumberofser has includpracticemanniquedynamsistancetop
,CHESthwestCentOfficer,Univthwest Centesinstructionothernon‐prtewidepainlhealtheducdtheMigraneer in El Saultural framional Interv
gInformatiwith the
er&druginfatchewanfans.Hehassover the lasvidenceasitaskatoonCiiatrics&reh
PharmD,BmicDetailinademicDetaserves asnings. AsAsicine,Dr. Kestinvestigatgh completiocertificateinary care rescal health pMedicalCen
oradoABCDfor8yearsphysicianassChild Healty, she complcedegreeinttingsforteded a varietynager.Thismicsandflowpracticesata
terforHealtversityofNeter for Healnaldesign, trofitorganizmanagemencatorforthentHealthNealvador. Shemework for iiewing and
ionSpecialiRxFiles A
formationspamilyphysicspentmanyst 20 years.relatestodityHospitalhabmedicine
BCPSngProgramailingsessioa faculty fssociate Proennedy is aor.Shehason of an Ahumanfactearch has blans. She hanter.
andbringswsistantdegrth Associatleted additiPediatrics.enyearsprioyofmedicarangeofexwinatypicameaningfu
thInnovatiewMexicolth Innovatiotrainingandzations.Shentinterventiecountyheaetworkinrure is a traineimproved cothe Stanfor
ist,RxFilesAAcademic Dpecialist.Ascians2‐3timhoursupdatHe is invol
drugtherapyfor over 30e.
m,OfficeofPons tooverfacilitator foofessor of Mresidency aextensivetrAHRQ‐fundedtorsandanebeen fundedas a clinical
withherexpeeattheUnte/Physicianonal courseMs.Craigwortojoiningl office posiperiencepocaloffice,whullevel.
ion
on in Silvertechnicalascurrentlyseon.PreviousalthdepartmralVirginia,ed medicalommunicatiod chronic d
ADProgramDetailing Prsanacademmesperyearting&creatlved in reviydecisionm0 years, he
PrimaryCar700participor NaRCADMedicine, Unand fellowshraininginred career deexecutivefeld by AHRQ, pharmacy
perienceinniversityofn Assistantework andworkedasagtheABCDitions fromositionsherhichallows
r City, Newssistancetoervesasthesly,shewasmentinFortandservedinterpreteron. She is aisease self‐
mrogram inmicdetailer,r,ontopicstingRxFilesiewing andmaking.Asahas a keen
re,UVMpants since Academicniversity ofhip‐trainedsearchandevelopmentllowshipinHRSA, thepractice in
![Page 17: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/17.jpg)
LynetteKosar,BSP,MScInformationSupportPharmacist,RxFilesADProgramFor the past 5 years, Lynette has been part of the RxFiles Academic DetailingProgram teamas an Information SupportPharmacist andAcademicDetailer. Shehasbeenthe leaddetaileronrecentRxFiles topics,and isacontributor/reviewerfor the RxFiles Drug Comparison Charts (10th edition), Geri‐RxFiles (2nd edition)and the RxFiles – Bringing Evidence to Practice section of the Canadian FamilyPhysicianJournal.Shealsoprovidesclinicalpharmacyservicesataheartfunctionclinic,isaresearchassistantwiththeprovincialdrugutilizationteam,andholdsaClinical Assistant Professor designation with the College of Pharmacy. Prior tojoiningtheRxFiles,Lynetteworkedasaclinicalhospitalpharmacist. HaraldChristianLangaas,MPharm,MPHManagingDirector,RegionalMedicinesInformation&PharmacovigilanceCentre(RELIS),Dept.ofClinicalPharmacology,St.Olav’sHospital,Trondheim,NorwayHaraldhasbeenworkingasmanagingdirectorforoneofthefourregionalRELIS‐centres in Norway for four years. At the department of clinical pharmacology inTrondheim he has teamed up with Dr. Roar Dyrkorn, who has beenworking tointroduceAcademicDetailinginNorwayforseveralyearsaftervisitingBostonandAustralia.TogethertheyhavebeenresponsibleforstartingthefirstAD‐programinNorway. Their team has completed twoAD‐campaigns, the first in 2015 and thesecondin2016.Haraldhasexperienceasahospitalpharmacist,andhasalsobeenapharmacymanagerforthreeprimarycarepharmaciesbeforejoiningRELIS.RELISalsooffersa teratology informationservice for thepublic,andaweb‐basedQ&A‐serviceaboutuseofmedicinesforthepublic.KarenLasser,MD,MPHAssociateProfessorofMedicine&PublicHealth,BostonUniversityDr. Lasser’s research focuses on improving quality of care in primary care forunderserved patient populations and reducing health disparities. Dr Lasser ismulti‐PI of a NIDA‐funded cluster randomized trial to determine whether fourimplementation strategies; nurse care management, use of a patient registry,academic detailing, and electronic tools, will increase primary care provideradherence to chronicopioid therapy guidelines and reduceopioidmisuse amongpatients, relative to electronic tools alone. Dr. Lasser’s work has receivedinternational recognition; she has published over 50 peer‐reviewed papers injournalssuchasJAMA,BritishMedicalJournal,andtheAmericanJournalofPublicHealth.Dr.LasserisapracticingprimarycarephysicianatBostonMedicalCenter,thelargestsafety‐nethospitalinNewEngland.
GailShaiLevine,MDMedicalDirector,BrighamandWomen’sPrimaryCareClinicatMassachusettsMentalHealthCenterGailhasbeeninterestedinprimarycareandhealthcaredisparitiessincemedicalschool.Forthepastfouryearsshe’sfullydevotedherprofessionaltimetomedicalcare for chronically severely mentally ill patients. Together with Dr. Viron andothers she is striving to create a fully integrated model of primary care in anambulatorymentalhealthsetting.
![Page 18: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/18.jpg)
TeDirBeDr.DruPhcomwoMeHowotheaca
CaCliPhDr.resUnScifrophThint
PrMaPritheAdwitprocarpos20
LoProLorsinmeandpramusertraconPra
errynNaurectorofEvneficiary&. TerrynNaug Intelligarmaceuticampleted ahorkedatSt.Pedicineandospital in ClorkinADine clinical phademicdeta
aitO’SullivinicalPharmarmacyPro. O’Sullivansidentialcarniversity ofienceinPhaomtheUnivearmacist werapeuticsIthedrugapp
riyankaRanagementAiyankagraduen went todministrationththeGraduogram throureer in the Vsitions,she15andcurr
orenRegieogramCoorren has guince the firstember of thd consultatiactical applultifaceted irves as aainings. Lorentributor/reacticesectio
umann,BSvaluation,DrPharmaceuaumann is thgence andal ServiceshospitalphaPaul’sasactheHIVCeninical Drug1993whenharmacist foilingprogra
van,BA,Bmacist,ContogramsBCPhas a clin
re,andcommNew BrunsarmacyfromersityofWaith the B.C.Initiative(Unprovalproce
Randeria,Analyst,VeuatedfromJo the Univen and aMasuateinHealtugh whichVA revenuejoined theentlyfocuse
er,BA,BSrdinator,Rxided the devground‐bree Canadianion to varioication of enterventionfaculty facien is co‐editeviewer fornofCanadia
ScPh,PharugIntelliguticalServicheDirector OptimizaDivision,rmacy residclinicalpharntreofExceResearch asheworkedor the CommminCanada
BScPh,PhtinuingMedProvincialAnical pharmmunitypracswick (HonmDalhousieashington.B. Provincialniversityofessandclini
MHA,MPteransHealJohnsHopkiersity of Wsters in PubthAdministshe won the cycle. AfteNational ADesonproject
SPxFilesADSevelopmenteaking pilotAcademicDusprogramevidence tons that suppilitator fortor ofRxFiler Geri‐RxFilanFamilyPh
armDgence&OpticesDivisionofOptimalation BranBritish Coldencyat St.rmacistinthllence.Shehand Drug UsdatLionsGamunity Drua.
harmDdicalEducatAcademicDeacy backgroctice.Sherecours, MedicUniversity,asedonVanAcademicBritishColucalpractice
PHlthAdminisinsUniversi
WashingtonblicHealth PtrationTrainhe nationaler a varietyD Service atmanageme
erviceof this provproject beg
Detailing Coms and initiao practice aport academNaRCAD’sesDrugComles and thehysicianjour
imizationBn,BCMinistrUse/Academ
nch, Medicumbia MinPaul’sHospheareasofPhasworkedse EvaluatioateHospitalug Utilizatio
tionIslandHetailing(PAound in acuceivedaBaccal AnthropandaDoctoncouverIslaDetailing (Pumbia).Caitguidelinem
stration itywithaB.to receivePolicy. SheningProgramACHE awaof project as a Manageentandfiscal
vincial acadgan in 1997ollaborationatives. Lorenand the ongmic detailingAcademic
mparisonCheRxFiles –rnal.
Branch,MedryofHealthmicDetailincal Beneficnistry of Hpital inVancPalliativeCaatVancouvon. TerryninNorthVan Program
HealthCliniAD)Serviceute generalchelorofArtpology), a BorofPharmaand,sheisanPAD) Servichasaresear
methodology
S.inPublica Mastersstarted hermattheMadard and proand datamement Analyloperations
emic detaili7. Loren isand providn’s interestsgoing develg. AdditionDetailing Tarts10thEdBringing E
dicalhngwith theciary andHealth. Shecouver andre,GeneralverGeneralbegan her
ancouveras– the first
ical
l medicine,tsfromtheBachelor ofacyDegreenacademicce and therchinterest.
Healthandin Health
r VA careerdisonVA,aopelled heranagementystin Aprils.
ing serviceactive as aes trainings cover thelopment ofally, LorenTechniquesditionand aEvidence to
![Page 19: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/19.jpg)
RoCoProRoMeyeaNaComonNe
JamPriDr.grainFelGoandme
JesAcaJesappknoexppromeguiinttoBrAcaBreSeracadetpramedecNupriacaacathe
obertRhy‐Director,Rofessor,Fambert Rhyne,exico, Reseaarsofexperational InstimmunityOrComplimenwMexico.
mesRick,imaryCare. Rick wasaduatedwithMedicinewllowship waldberg.Heid ChairmanemberatUC
ssRogersademicDetss overseesproach to dowledgetraperience adoviders. Jesethodologyfidance forterventionsenhanceevi
rendaSchademicDetenda Schusrvice in Reademic detatailing serviacticeattheedicine residcisions.Sheutrition,Univimary careademic detaademicdetaeUnitedStat
yne,MDResearchCormilyandCo, MD, is co‐arch Involvinrienceinpriitute of HerientedPrimntaryandAlt
,MDePhysicianeducated ahboththeMasatLACouas in ClinicastheOpiaten of the PhIrvineDepa
stailingServithe Centredetermininganslationanddressing thss’s leadersforthesearchealth ca
andimplemidence‐based
huster,BStailer,RxFileter is an aegina, SK, Cailing technices for theeAcademicdents andwis a ClinicaversityofSapharmacy
ailing trainiailer trainingtes.
reistheVicmmunityMfounder of tng Outpatiemarycare,halth fundedmaryCare,coternativeMe
atLongBeat the UnivM.D.andPh.Dunty(USC)aal PharmacoeSafetyInitiharmacy anartmentofM
iceCo‐Direcfor Effectivg the best edinter‐profe researchship role ach,appraisalare professmentationprdperforman
SP,ACPR,esADServicacademic deCanada, andniques coure last 15 yeFamilyMedworks alongsal Assistantaskatchewanresidents.
ings for Rxg skillswork
ceChairofRMedicineDepthe practiceent SettingshasbeenPId projects,ommunity‐bedicine(CAM
eachVAMedversity of IlD.(PharmacandUniversology at theiative(OSI)d TherapeuMedicine.
ctor,Centree Practice’sevidence infessionalcarand evidenat CEP incllanddissemsionals. Jessrojectsthrounce.
PharmD,ceetailer withd a trainingrse. Brendaars and shedicineUnit.side them tProfessorwnandapreBrenda ha
xFiles on nekshops for a
Researchpartment,Ue‐based reseNetwork (andco‐inveand has cobasedmedicM)useinHi
dicalCentellinois Medcology).HissityofSouth UniversityPointofConutics Comm
eforEffectiv(CEP, Toro
n areas suchredelivery.Jce needs ofludesdevelominationofes also cooughpartner
FCSHP the RxFileg facilitatora has beene combinesSheis involo assist in twith the Colceptor forhas been inew topics aacademicde
UNMearch netwoRIOS Net).estigatorononducted raleducationispaniccomm
er(VALB)ical SchoolPostGraduahCarolina(Mof ChicagontactatVALmittee. He is
vePracticeonto, Canadah as clinicaJesshasovef decision moping an aevidence‐baordinates enetworksw
es Academicfor NaRCA
n providingthis with hlvedinteachtheir daily pllege of Phahospitalphanvolved inand has coetailers inC
ork in NewHe has 25nnumerousesearch innaswellasmunitiesin
where heatetrainingMUSC).Hiswith LeonLongBeachs a faculty
a) rigorousal practice,er12years’makers andappropriatesedclinicaleducationalwithaview
c DetailingAD's 2‐dayg academicher clinicalhingfamilyprescribingarmacy andarmacyandfacilitatingo‐facilitatedCanadaand
![Page 20: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/20.jpg)
JackiTravers,PharmDClinicalAcademicDetailingPharmacist,PharmacyManagementConsultantsJackijoinedPharmacyManagementConsultants(PMC)in2015astheirfirstandonlyacademicdetailingpharmacist.ShehasbeenactiveinthedevelopmentandimplementationofPMC’sacademicdetailingprogramaspartofitsservicetoOklahomaMedicaid.PriortojoiningPMC,sheservedinthepracticesettingsofindependent,hospital,andclinicalpharmacy.ShereceivedaB.SdegreefromtheUniversityofColorado,andaDoctorofPharmacydegreefromtheUniversityofOklahoma.Herprogrameffortsfocusonbridgingthegapbetweeninformationandapplicationinordertoprovidequalityhealthcareinafiscallyresponsiblemanner.MarkViron,MDDirectorofHomeHealthServices,DepartmentofMentalHealth’sMassachusettsMentalHealthCenter(MMHC)Dr.VironisanadultpsychiatristatMMHCinBostonandanAssistantProfessoratHarvardMedicalSchool. Hespecializesinthetreatmentofpsychoticdisordersandtheintegrationofprimaryandbehavioralhealthcareforpeoplewithseriousmentalillness.HegraduatedfromTulaneUniversitySchoolofMedicineandcompletedhispsychiatryresidencyattheMassachusettsGeneralHospital/McLeanResidencyProgram.HeservesasanattendingatMMHC’spartialhospitalprogram,whereheteachesandtrainsresidentsandmedicalstudents.Heisalsotheprojectdirectorfortwogrant‐fundedinitiativesthataimtoenhanceMMHC’sabilitytoprovideintegratedprimaryandbehavioralhealthcare.ShirleyYeung,BSc(Pharm),ACPR,MScAcademicDetailingPharmacistShirleyYeungisanacademicdetailingpharmacistwiththeBCProvincialAcademicDetailing(PAD)service.ShirleyobtainedherBSc(Pharm)fromtheUniversityofBritishColumbiaandthencompletedahospitalpharmacyresidencywithVancouverCoastalHealth‐ProvidenceHealthcare.SherecentlycompletedherMScinPublicHealthintheHealthEconomicsstreamattheLondonSchoolofHygieneandTropicalMedicine.ShirleyhasbeenwithPADsince2010andcoverstheareasofVancouver,Richmond,BellaCoolaandBellaBella.Shehasprovidedsessionsoneightdifferenttopicstohealthcareprovidersintheregion.SheisalsoapreceptorforthehospitalpharmacyresidentsoftheLowerMainlandPharmacyServices.KathrynZioto,MDPsychiatrist,CodmanSquareCommunityHealthCenterKathrynZiotoisanadultpsychiatristatCodmanSquareCommunityHealthCenterinDorchester,Massachusetts.SherecentlygraduatedfromtheHarvardLongwoodPsychiatryResidencyTrainingprogramwhereshespentherfinalyearworkingwithHealthcarefortheHomeless,providingintegratedpsychiatrytotheirstreetteampatients.SheisnowembeddedwithinprimarycareatCodmanSquareHealthCenteraspartofanewhealthcenterinitiativetointegratethedeliveryofbehavioralandphysicalhealthcaretoCodmanpatients.Whileinresidency,sheworkedwithDr.MarkVironandDr.GailLevineatMassachusettsMentalHealthCenterandwiththeNaRCADteamtoprovideacademicdetailingtopsychiatristsregardingtobaccotreatmentforpeoplewithseriousmentalillness.
![Page 21: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/21.jpg)
TCo
ismadep
by
Thank orefundingpossibleby
Theyasponsor
You tgforNaRCytheAgenc
2016Confrshipfrom
to Ou
AD&theAcyforHealt
ferencewaourcollea
r SpoADConferethcareRese
assupporteguesatAlo
onsors enceSeriesearchandQ
edosaHealth.
Quality.
![Page 22: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/22.jpg)
Smok
Patients20‐yearayear’sfeaMentalHthisappr
Safepresstudies,AMDA, tidentifyohopesto
AsHIV twill requthepastthe uptadevelopmtheeffort
Searchou
king Cess
withseriouaveragelifeaturedpresHealthCentroachtopat
R
scribingforand the tothe nationaopportunitireducepol
treatmentsuireeducatyearwehaake of HIVment, and ittoeventua
abourblogarc
sation Tre
usmentalieexpectancsentationoter,wearetientsstate
Reducing
rnursing‐hopic remainal associatiiesforADilypharmacy
HIV S
have imprtionofhugeaveworkedV pre‐expoimplementallyreduce
uttheintechivesbyc
greatm
eatment f
illnesssmocyreductionnADtoincexcited to
ewide.
Polypha
omepatienns pressingon of medinterventioyinlong‐te
Screening
roved, the fenumbersdwithmultosure propation. Thesetherateof
Leaerventionsclinicaltopmarketing
for Patien
okeathighenduetosmcreasesmokbecollabo
rmacy in
ntswastheg today. Ovdical directnsandareermcare.
g & PrEP I
focus has sofprimarytiplegroupphylaxis, prsemodel infnewHIVc
arn mosthatarespic,orvisit&educati
nts with S
erratesthamoking‐relakingcessatoratingona
Long-ter
efocusforover the paors in possupporting
Implemen
shifted to pycareprovpsusingADroviding snterventioncasestozer
ore shapingthtourLearnonalmate
Serious M
anthegeneatedillnessetiontreatmaPCORI‐fu
rm Care
oneofJerryast year wet‐acute andganADpro
ntation
preventingvidersacroDtoimprovupport onnswill proo.
hefieldofAningCenteerials.
Mental Illn
eralpopulaes.InadditentatMassundedstudy
yAvorn’soe have wod long‐termograminIn
transmissioss thecounveHIVscren training,vide key le
AD.erforexam
ness
ation,withtiontothissachusettsybringing
riginalADrked withm care, todianathat
ion,whichntry.Overeeningandmaterialsessons for
mplesof
![Page 23: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/23.jpg)
Ourparvia cliniresource
They'reline dechighligh
NaRCADscreeninprescribandmor
Visitou
Contactu
rtners areical educatesharing,
e improvicisions. Ouhtsbestpra
D partnerng, improvbingofopire.
rPartnerN
usifyou’dsup
e organization progrtrainings,
ng healthur partneracticesint
r programved accesioids,incre
naNetworkospecialty
liketobelpportersw
ations or inram suppoconferenc
h outcomer networkthefield.
ms in 201ss to sexueasedrefe
arcad.online,andy,andourg
listedaspworkingtog
ndividualsort, materes,blogfea
es throughconnects
16 have sual healthrralstoch
org/padsearchouglobalalp
artofourgethertoi
swhohavials develoatures,and
h provideexperts,
successfulltesting r
hronicdise
artnersurdirectorhabetical
communitimprovepa
e collaboropment, pdsponsors
r educatioshares im
ly increaseresources,easemana
s
ryofpartnlisting.
tyofclinicatientcare
ratedwithprogramevships.
on, informmportant w
ed rates oencourag
agementsp
nersbyloc
caleducatoe.
NaRCADvaluation,
ming frontwork, and
of cancerged saferpecialists,
cation,
orsand
![Page 24: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/24.jpg)
W
Weofferaueducators
role
uniqueands.We'rewi
play, lenetw
ddynamiccthyoueach
dive
ecture, dworking,
coursethathstepoftherselearnin
iscussion expert
1
tprovidesheway,offngplatform
n, small panels,
acriticalfoferingpersoms,featurin
group bmodelin
oundationonalizedinng:breakoutng, & mo
forclinicalnstructiont
t sessionore.
loutreachthrough
ns,
![Page 25: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/25.jpg)
![Page 26: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/26.jpg)
C
withqu
Catch u
uestions,
up on y
requests
your re
Cotohaveyonarcad@
eading—
FeoseinGaimpinmpAhfo
ontact uourprogr@partne
—every
Fromintervexpertstoeoffaroundtselectsthebeducationanbox.
Grabacupacademicdmpact,frompopulatedcnterventiomanagemenprogramstADasitconhelpingthefortheirpa
usramfeatuers.org
y last d
viewswithexcitingnewthecountrybestofclinanddeliver
ofcoffeeanetailingismruralarecities.Covens,fromHnt,we’rewohighlightntinuestoimtomakeatients.
ured,&con
detail.
hacademicwinitiativey,DETAILSnicaloutrearsitrightto
ndseehowmakingalaeastodenseringdiverIVPrEPtoworkingwittthemoveminformclinethebestd
ntentsha
detailingestakingShandachoyour
wastingsely‐sediabetesthmentofnicians,decisions
aring.
![Page 27: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/27.jpg)
“PJe
TquDjonsaWmdmcodplein
anTinJorelik
ProfessioerryAvor
hen,forreasuarterbacks
Deliveringprobasever,bowstandingank,andPCP
Whatdoesallmostfrequenegradationhmedicationsmonsultationsaily.IntheOathologicallyeftinthehanndividuals.
nddisrespec
hatwouldhnsurancereqohnsonbetteecommendakethehealth
onalism, rn,MD,Na
sonswedonsgotrecasta
rimarymediutthestaturgfor‘providPburnoutan
lthishavetontandvisiblehasdevelopmostoften,bs,andmanyOldenTimesyheterogenndsofthePC
ctfulofthen
helpprimaryquirements,erthanherdationsthatthhcareprofe
AcademaRCADCo‐
n’thavethesasgatekeepe
calcareremreanddailyer’)becamenddropoutb
odowithacewaysthattedisintherbutalsoabootherchoices,whichstillneouscoveraCP,andares
Increrequthouocca‘freeandButs
needsofspe
ycarecliniciorcomputedoctordoes.hemoreenliessionalswe
ic Detail‐director
spacetodiscers,andthen
mainedasinnworkofthedegradedinbecamemor
cademicdetathequarterbroleofclinicouttestordeestheprimasurviveinsagesystem,tstillmadew
easingly,sucuirements,alughtful,evidasionalwildedom’whichhealthcare
sometimestcificpatient
ansmakebeer‐basedalgo.Itcouldalsightenedpolspentsoma
ling, and|DETAILS,20
TherestartingmedicalPrimaryabovethrecognizhealthcallalonggrowingaccompacatapult
cusshere,innasswitchb
natelyvitalaePCP(withtnmanysettirecommon.
ailing?Alot.back‐to‐gatecaldecision‐ring,specialarycareclinomepocketthesedecisioellorpoorly
chchoicesalgorithms,aence‐basedandcrazychhcanonoccbudgets.
therestrictiotsandthenu
etterdecisioorithmsthatopavethewliciesseektoanyyearsle
d the Rep016
ewasabintheearlyschool,thatycarephysicheirlowest‐izedforplayiaresystem(g).InmedicaginterestinanyinginsurtPCPsfrom
nthefollowiboardoperat
andsacredathesecondPings.Morale
Oneoftheekeepermaking–folisticianfacestsofouronsarestillyby
redrivenbyandotherresguidancesthhoicessomeasionleadto
onsaresimpuancedjudgm
onswithoutatsometimeswayforwideoachieve.Anarninghow
pairing of
brief,shiy1970s,whetlastedintocians(PCPs)in‐medicineingacentral(as,ofcoursalcentersth‘healthmainrancedesigntheroleofn
ngyearsinmtors.
aP
r
yformulariestrictions.Sohatareusefuepractitioneopotentialh
ple‐minded,mentofthe
allthelimitasfunctionaseradoptionondclinicianstobe.
f Primary
iningmoenIwasfinisaboutthem)seemedpoistaturetoblroleinthee,theyhadbhroughoutthntenance’annsseemedpnerdstoqua
manysetting
s,priorauthometimesthulantidotesrsoccasionaharmtoboth
financially‐dindividualc
ationsofarbiftheyknowoftheevidenscouldagain
y Care”
omentshingmid‐1980s.isedtorisebecomeentirebeendoinghecountry,nditspoisedtorterbacks.
gs,the
horizationhesearetotheallymake–hpatients
driven,linician.
bitrarywMrs.nce‐basednfeelmore
![Page 28: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/28.jpg)
P
Nbyo
MabOnoneqedouItskpOimH“gMdorpsere
PublicHealth
NaRCAD:Theingdonebourselfand
Michelle:AltboutasanoOutreachRepotonlytoprnspecificcoquatetobeiducation,firutreachand
t’sessentialkills,sowherovidersareOne‐on‐onepmportantiti
Howcananogetonboar
Michelle:Leifferentreasrdon’thaverovidersareetgoalsandecommenda
“NEmpow
hDetailingFeaturing
anksfortakbytheNYCDdhowyoug
thoughevideoutreachreppresentativeresentthecaontentareasngeffective!rstandforemdcommunica
ourrepshaventheyengaethenequipproviderengistohavea2
outreachrerd”andthin
et’suseobessons.Providethesamekien’tusinggrtakesmallsationsandre
New Yowering
ProgramagMichelleDr
kingthetimDepartmengotinvolved
MicheDetailithenonYorkCbeeninprovidtailorinFosterclinicaoutrea
ence‐basedrresentative,e(detailer)nampaign,busuchassmo!Althoughmmostwelookation.
veexcellentgeproviderpedtogetthgagementhe2‐waycomm
epresentatinkaboutcar
ityasanexaersmaybefindsoftoolsreatcommunstepstowardeframesthem
rk CityProvide
atNewYorkresser,MPH,
DETAILS
metosharentofHealthdinpublich
lle:ThankyingProgramn‐profitandCityDOHMHnhealthcaredersandconngcomplex
ringthatkinaloutreachachreprese
recommend,it’sreallyabneedstobeauttocultivatokingcessatmostofourrktobringon
sellingandsandgettheheirpatientselpsthemunmunicationw
iveencourareasadialo
ample.Withfrustratedthstotreatobenicationtechdsthegoal.Wminorderto
's Healters to Im
CityDepart,SeniorManSINTERVIEWS
thegreatcandMentahealth,spec
youfortheom.Ihaveoverdgovernmen.Throughouemarketingnsumerscanmessagesus
ndofprovideducation.entativetru
dationsprovibouthowyoanexcellentelong‐termtion,hyperterepshaveanteammem
communicaeirbuy‐in,s“onboard”nderstandhowithpatients
ageprovideogue?
obesity,bothatpatients’esityastheyhniques,likeWeworkonocustom‐tai
th Depamprove
tmentofHeager,PrograSERIES
clinicaloutrlHygiene,Mcificallypub
opportunitytr20yearsofntsetting,wiutmyprofesandprovidebettercommsinghealthl
der‐patientInyourexpulyskilleda
idetheframoudeliver,ocommunicarelationshipension,diabebackground
mberswhoha
tions
”.ows.
ersto
thproviders’comorbidcydoothercoemotivationn“coachingsilortheconv
artmente Outco
ealth&Menamming&St
reacheducaMichelle!Teblichealthd
tospeakabofpublichealiththelast1sionalcareeereducationmunicatewiliteracyprin
tengagemeperience,wandsuccess
meworkforwr"sell"thosatoraswellaps.Justbecaetes,etc.,itddinpublicheaveexperien
sandpatientconditionsaonditions;panalinterviewscripts”,whiversationfor
t: omes”
talHygienetrategy
ationworktellusabitadetailing.
outthePubllthexperien12hereatther,myspecian,emphasizinitheachothenciples.
entisacritiwhatmakesful?
whatyou’llsemessages.asapersuasauseyou’rewdoesn’tneceealthorhealnceandsucc
tsarefrustrarebeingexaatientsmighwing(MI),tochtakethekreachpatien
e(DOHMH)
that’sabout
icHealthnceinbothheNewaltyhasnghowerby
calgoalofan
peakTheiveperson,wellversedessarilylthcessin
ated,foracerbatedhtfeelthathelpthemkeynt.
![Page 29: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/29.jpg)
Ifapatientisonlytold,“Youneedtoloseweight,”whichissuchabroadandoverarchinggoal,they’llbefrustrated,andfrankly,non‐adherent.IknowIwouldbe.Encouragingproviderstohavespecificdialoguesusingacustomizedapproachforeachpatientisimportant.Thiskindofdialoguetakesintoaccountpatients’literacybeyondthewrittenandspokenword—itlooksatscientific,fundamental,healthandculturalliteracy,too.Fosteringthatdialogue,andhavingtherighttoolsandresources,iscritical.Howwouldyoudescribeyourprogram’soverallapproachtoprovidereducation?Michelle:Ourfocusisontheentireintervention,notjustaboutmanagingortreatingadisease,butpreventingitfromeveroccurringinthefirstplaceaswell.We’reempoweringproviderstoworkonpreventivestrategieswiththeirpatients,whichcantranslatetobetterproviderandpatientoutcomes.Onethingthat’suniqueaboutpublichealthdetailingisthatwedetailthewholeteamthroughone‐on‐oneinteractions.Evidenceshowsthesetypesofinteractionswithprovidersandstaffaremoreeffectiveatchangingbehavior;however,sometimesduetothemakeupofthepracticewemustconductgrouppresentations.It’snotideal,butitstillallowsustogetthemessagesandmaterialsoutthere.Thelandscapeofhealthcarehaschangedsomuchandismoreteam‐based;weknowtheprovidercan’tdoeverything,sowelookatthebigpicture:whohelpswithintake,counseling,follow‐up?Weconsiderit“thetotalofficecall.”Wedon’tusetheterm“gatekeeper”—wetrainpeoplethateveryoneinthepracticeistobeapproachedanddetailed,whetherit’sadministrative/frontdeskstaff,billers,nurses,providers—everyoneplaysavitalroleinapatient’shealthcare.Sowhenanoutreachrepresentativegoesintoanoffice,theydetail...everyone?Michelle:Ifthereare15peoplewhoworkinanoffice,we’regoingtodetailall15ofthem.It’salot!Sometimes,thepersonwhoisthechampionofanewbehaviororworkflowisn’tgoingtobetheprovider.Weseethefrontdeskstaffasinstrumental;they’reinteractingwithallofthepatients.Weworkwithourteamstoensureeventhefrontdeskstaffreceivesthematerialsandinformation,ratherthanseeingthemmerelyasa“gatekeeper”togettotheproviders.Soundslikealotoftraininggoesintopreparingforyourcampaigns,andforthinkingabouttheentireprocessofeffectiveoutreach.Tellusmoreaboutyourtrainings,andhowyouprepareoutreachrepresentativesondiseasecontenttraining,aswellascommunicationsskills.Michelle:Onaverage,ourtrainingsareabout5daysinlengthandtakeplacetheweekpriortolaunchinganewcampaign.About40percentofthetrainingisdiseasecontent,soweworkwithourinternalHealthDepartmentexperts,aswellasexternalexperts,wherewelearnaboutpreventionstrategies,treatmentstrategies,epidemiologyandthelandscapearoundthekeyrecommendationschosenbasedontheevidenceofthattopic.Weneedtoknowthe‘why’behindthecampaign.
![Page 30: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/30.jpg)
Ofr“fanfrpWancowD
H
MthgrthmbW
buwreuH
Mevpfo
Oncewehaverametheissufeaturesandndfinally“grompharmaublichealth
Wealsodoanalysisofeaommunicatiwell‐prepareDepartmento
Howelsedo
Michelle:Whefield80%reatopportuhey’vefacedmaterialstolarriers,butWhat’sama
uy‐inthatnewetryandlimelationship.scomeback
Howdoyou
Michelle:Evvaluateeffecroviderpracollow‐upvis
ethatunderue,howtopdbenefits”asgainingacomaceuticalmarinteraction
greatdealoachrep.WelonskillsaredtogooutaofHealthan
esyourtea
emeetthrou%ofthetimeunitytocomonthegroulogisticslikeit’snotuntiljorbarrier
eedstohappmitgroupprOncetheygktoconduct
knowwhen
valuationisactiveness.Fctice.Thisait.
rourbelt,wepromotetheswellasthemmitment”,wrketing.Wes,sowewor
froleplayinlookatbodyeeffective,wanddetail.WdMentalHy
mstrategiz
ughoutthec,4outofthe
metogetheraund.Itcouldeparkingnealwe’reouttyourprogr
penforpeopresentationsgettoknowu1:1visitson
nacampaig
alwaysonthoreverycamallowsustos
eshifttosesmaterials,fie“barriersanwhicharephe’re“selling”rkonthoses
ng,includingylanguage,wwedoknowleWetakethisygiene.
zewhenpro
campaigntoe5daysofthasateamanbeanythingarpractices.herethatweramhasfac
pletocomeis,thishasprusandrecognthefollow‐
gnisworkin
hetopofourmpaignwecseeifthereh
ssionsonhoiguringouttndobjectionhrasesthatcandpromotskills.
gvideotapedwhatedgeassessmseriously—t
omotingnew
talkaboutwheweeksotndstrategizegfromacces.Duringtraieseewhat’sed,andhow
inandtalktroventobeagnizetheval‐upandsubs
ngandbeco
rpriorities,aconductaninhasbeenac
wtothens”cometing
d
ments,quizzthey’rerepr
wcampaign
what’sworktheonedaye.Weaskthesstouptakeining,wetrysreallyhappwhaveyou
MistaaccsyschaanmawasmanWh
Mihavins
othestaff.Aaneffectiveslueoftheprsequentcam
omingsucce
andcanbeanitialandfohangeinpra
zes—wemaresentingthe
ns?
kingandwhaaweektheyemtoreportofrecommeytoanticipatpening.tackledit?
chelle:Abiartingadetacess.ThelanstemsinNYCangedovertexample,seajorityofourasalmostentmallpracticesissue.
hat’schang
chelle:Nowvebecomepstitutions,soAsImentionstrategywhrogram,theympaigns.
essful?
achallengefllow‐upvisiacticefromt
akesureoureNewYork
atisn’t.Ouryareintheotoutonwhaendationsanteandprepa
igchallenge,ilingprograndscapeofhChasdrasticthepastfeweveralyearsrBrooklynttirelymadeswhereacce
edsincethe
w,manyofthpartoflargerothere’scorpnedbefore,aenenteringy’reengaged
foranyprogritwherewetheinitialto
teamis
staffisinofficeit’saatbarriersndarefor
,whenm,isealthcarecallywyears.Asago,theterritoryofupofesswasn’t
en?
hesesitesrporatealthoughintoanewdinhaving
ramtoassessothe
![Page 31: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/31.jpg)
Asutoac
Tsu
orgrim
Additionally,upportingtoogainingamccessandm
That’ssoheluccess.Wra
rganizationareatestimpamportantto
For
weratewhaoolsandresomorecompleaterials.
lpful—progappingup,w
alpriorities.act.Programlookatthed
rmoreinter
atprovidersources.Weaetepictureo
gramswesuwhatother
.Ourprogramsshouldmdataandpla
rviews&pr
sintendtoaalsocollectaofthecampa
upportareakeyadvice
Michprogrthelaofnonecessellinisweinfordetai
Youcamfocusesomakesuretoanthebestc
racticehigh
doptintermalargeamouaign’ssucces
alwayslookwouldyou
helle:Onekramsaboutaunchofacaotonlytheclssarybackgrngandcommell‐prepared,mationtothilingprogram
canscalethionwherethelookattheirourseofacti
hlights,visi
msofthekeyuntofqualitass,especially
kingforinnofferforne
keypointthaistheimporampaign.Icalinicalcontenroundandemunications,confidentahepracticesm.
supordowere’sthegrerorganizatioionwithinth
ittheDETA
Subscr& be comm
Visit&sig
You’llre‐newsopportu
opportuncolleagues
E‐mail
yrecommenativedatabeywhenrepo
novativewaewanddev
atIalwayssprtanceofaroan’temphasntportion,wevidenceforskillssessioandexcitedtisthecorne
wn,dependinatestneedaon’sagendahecapacityy
ILSBlogat
Join ribe to part ofmunity
tusonlineagnupforou
eceivethesletter,updunitiesandnitytosharswithinou
Questi
usatnarca
dationsandecauseit'sartingonbar
aystomeasuvelopingpro
peakwithinobusttraininsizeenoughwhichprovidthecampaigons.Havingatobringthiserstonetoas
ngonyourneandpotentiaandgoals.Ityouhave.
tnarcad.org
Us. our netf our onof expe
atnarcad.ourmailingl
latestblogdatesontradevents,anreyourwourpartnern
ions?ad@partner
alsocriticalrriers,
ureograms?
nterestedngbeforethevaluedesthegn,buttheateamthatsuccessful
eedandalfort’s
g.
work nline erts
orglist.
gs,ourainingndtherkwithnetwork.
rs.org
![Page 32: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/32.jpg)
![Page 33: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/33.jpg)
Notes Page
![Page 34: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/34.jpg)
Notes Page
![Page 35: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/35.jpg)
Notes Page
![Page 36: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/36.jpg)
Notes Page
![Page 37: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/37.jpg)
Notes Page
![Page 38: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/38.jpg)
Notes Page
![Page 39: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/39.jpg)
Notes Page
![Page 40: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/40.jpg)
Notes Page
![Page 41: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/41.jpg)
Notes Page
![Page 42: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/42.jpg)
Notes Page
![Page 43: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/43.jpg)
Notes Page
![Page 44: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/44.jpg)
Notes Page
![Page 45: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/45.jpg)
Notes Page
![Page 46: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/46.jpg)
Notes Page
![Page 47: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/47.jpg)
Notes Page
![Page 48: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/48.jpg)
Notes Page
![Page 49: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/49.jpg)
Notes Page
![Page 50: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/50.jpg)
Notes Page
![Page 51: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/51.jpg)
Notes Page
![Page 52: M MS, NaRC erry Avorn RCAD Co-Director · 1:35 – 1:45 Presentation: “The Impact on Academic Detailing of a Drug Therapy Point of Care Tool/Resource (RxFiles Drug Charts)” Brent](https://reader036.vdocuments.mx/reader036/viewer/2022071606/6142998d415ba25fca5f0152/html5/thumbnails/52.jpg)
Notes Page